Data for this review were obtained by searching Medline using the terms “occult hepatitis B” as well as the related terms: “inapparent HBV infection”, “serologically silent hepatitis B”, “silent hepatitis B”, and “surface antigen negative carriers”. Only English language articles were selected. Article abstracts were then reviewed to identify studies in HCV-infected patients. In addition, reference lists of the selected articles were examined to identify additional studies. References
ReviewOccult hepatitis B
Section snippets
Overview
Individuals with occult hepatitis B by definition are HBsAg negative. HBeAg is detectable only rarely. Individuals are variably positive for surface and core antibody, though about 20% are negative for all markers of past HBV infection aside from HBV DNA. Since viral DNA levels in occult hepatitis B are very low, the identification of occult hepatitis B is strongly dependent on both the sensitivity and specificity of the assay.
Whereas this is generally true for all laboratory-based diagnoses,
Overview
Although the presence of occult hepatitis B in chronic HCV infection is well established, the clinical relevance is still being assessed. Nevertheless, occult hepatitis B has been associated with advanced fibrosis/cirrhosis in cross-sectional studies and with poor interferon α response in several treatment studies (table 6). Occult hepatitis B has likewise been reported in a high proportion of HCV-infected patients who develop hepatocellular carcinoma. Although only limited clinical and
Possible mechanisms
The molecular/immunological mechanisms underlying occult hepatitis B infection remain incompletely defined and are probably multifactorial. On the one hand, occult hepatitis B could merely show the greater sensitivity of the PCR-based testing used to detect HBV DNA, compared with the enzyme immunoassay tests used to detect serum antigens. In some cases, mutations in the hepatitis B surface gene could substantially reduce the sensitivity of the HBsAg assays by making the surface protein less
Conclusions
Occult hepatitis B is defined by the presence of HBV DNA in the serum or liver of people without HBsAg. Occult hepatitis B can be identified in a substantial subset of HCV-infected people, especially in those who are positive for HBcAb. Serum HBV DNA levels are characteristically low, but despite the low replication rate, HBV DNA detection can be associated with ALT flares and is associated with advanced fibrosis/cirrhosis. In addition, occult hepatitis B is associated with decreased interferon
Search strategy and selection criteria
References (79)
Hepatitis B: global importance and need for control
Vaccine
(1990)- et al.
Treatment of chronic hepatitis B
Lancet Infect Dis
(2001) - et al.
Management of hepatitis B: 2000—summary of a workshop
Gastroenterology
(2001) - et al.
Chronic hepatitis B
Hepatology
(2001) - et al.
Hepatitis B e antigen-negative chronic hepatitis B
Hepatology
(2001) - et al.
Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers
J Hepatol
(2002) - et al.
Role of silent hepatitis B virus in chronic hepatitis B surface antigen liver disease
Antiviral Res
(2001) - et al.
Serum hepatitis C virus RNA and hepatitis B virus DNA in non-A, non-B post-transfusional and sporadic chronic hepatitis
J Hepatol
(1992) - et al.
To kill or to cure: options in host defense against viral infection
Curr Opin Immunol
(1996) Occult hepatitis B virus infection and liver disease: fact or fiction?
J Hepatol
(2001)
Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely “occult”?
Hepatology
Occult hepatitis B virus infection
Dig Liver Dis
Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers
Hepatology
High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology
J Hepatol
Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus
J Hepatol
Hepatitis B virus DNA in sera and liver tissue of HBsAg negative patients with chronic hepatitis C
J Hepatol
The impact of previous HBV infection on the course of chronic hepatitis C
Am J Gastroenterol
Comparison of commercial assays for the quantification of HBV DNA load in health care workers: calibration differences
J Virol Methods
Hepatitis C and B viruses in hepatitis B surface antigen-negative hepatocellular carcinoma
Gastroenterology
Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action
J Hepatol
Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma
Hepatology
Identification of differentially expressed genes in hepatocellular carcinoma with cDNA microarrays
Hepatology
Identification of hepatitis B virus integration in hepatitis C virus-infected hepatocellular carcinoma tissues
J Hepatol
Isono K. Detection of hepatitis B virus x transcripts in human hepatocellular carcinoma tissues
J Surg Res
Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study
Gastroenterology
Transmission of hepatitis B from hepatitis-B-seronegative subjects
Lancet
The risk of transfusion-transmitted infection
N Engl J Med
The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study
N Engl J Med
The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies
JAMA
Prevention of perinatal hepatitis B through enhanced case management—Connecticut, 1994–95, and the United States, 1994
MMWR Morb Mortal Wkly Rep
Viral hepatitis in health care personnel at The Johns Hopkins Hospital. The seroprevalence of and risk factors for hepatitis B virus and hepatitis C virus infection
Arch Intern Med
Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases
J Infect Dis
Detection of hepatitis B virus DNA directly in human serum by a simplified molecular hybridization test: comparison to HBeAg/anti-HBe status in HBsAg carriers
Hepatology
e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants
N Engl J Med
Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B
J Viral Hepat
Frequent detection of hepatitis B virus X-gene DNA in hepatocellular carcinoma and adjacent liver tissue in hepatitis B surface antigen-negative patients
Dig Dis Sci
Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants
Transplantation
Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease
N Engl J Med
Hepatitis B virus (HBV) reactivation after cytotoxic or immunosuppressive therapy—pathogenesis and management
Rev Med Virol
Cited by (479)
Prevalence of occult hepatitis B virus infection in Egypt: a systematic review with meta-analysis
2023, Journal of the Egyptian Public Health AssociationThe impact of hepatitis B virus and hepatitis C virus infections in patients with Hodgkin's and non-Hodgkin’s lymphoma
2023, International Journal of Immunopathology and PharmacologyHepatitis B virus-induced hepatocellular carcinoma: a persistent global problem
2023, Brazilian Journal of MicrobiologyAntibodies to Hepatitis B core antigen prevalence study in Kazakhstan
2023, Immunity, Inflammation and Disease